Literature DB >> 2022520

High-dose-rate afterloading technique in the radiation treatment of uterine cervical cancer: 399 cases and 9 years experience in Taiwan.

M S Chen1, F J Lin, C H Hong, C P Tu, J H Lan, S G Tang, W M Leung, T R Wang.   

Abstract

Carcinoma of the uterine cervix has been the leading malignant neoplasm treated in our department. A comparative study was carried out using conventional low dose rate (LDR) with 137Cs sources (less than or equal to 100 cGy/hr) versus high dose rate (HDR) with 60Co sources (greater than 100 cGy/min) in the intracavitary (IC) application following external pelvic irradiation. A total of 399 patients were treated with external RT plus HDR radiation treatment alone from February 1980 through December 1985. Stage IIb and IIIb comprised 79.4% of cases (317 cases). The rate of initial complete response of the tumor, local control, and survival rate seemingly were better in the HDR group, but there was no significant difference statistically. The actuarial survival rates in all cases/definitive RT cases are 85%/85% for Stage 0-IIa, 53%/70% for IIb, 43%/49% for IIIa, 43%/53% for IIIb, 42%/47% for IVa, respectively. Complications were similar and the rectal complications were slightly higher in HDR group. The combination of pelvic irradiation with HDR intracavitary irradiation was more convenient for patients and also for personnel. The HDR technique may be a good substitution for IC treatment.

Entities:  

Mesh:

Year:  1991        PMID: 2022520     DOI: 10.1016/0360-3016(91)90185-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Ultrasound-assisted endocavitary HDR-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability.

Authors:  Georgios V Koukourakis; Anthoula Miliadou; Ioannis Tsalafoutas; Myrsini G Gkeli; Elisavet Geli; Anastasia Sotiropoulou-Lontou
Journal:  Clin Transl Oncol       Date:  2012-07-19       Impact factor: 3.405

2.  Evaluation of Survival and Treatment Toxicity With High-Dose-Rate Brachytherapy With Cobalt 60 in Carcinoma of Cervix.

Authors:  Afshin Rakhsha; Amir Shahram Yousefi Kashi; Seied Mohsen Hoseini
Journal:  Iran J Cancer Prev       Date:  2015-08-24

3.  A review of nonstandardized applicators digitization in Nucletron™ HDR procedures.

Authors:  Kelin Wang; Michele S Ferenci; Alberto de la Zerda; Kyle R Padgett; Elizabeth L Bossart; Ming Chao; Hua Shao; Mutain Zhang
Journal:  J Appl Clin Med Phys       Date:  2017-08-30       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.